Cheng Chen

5.7k total citations
87 papers, 3.3k citations indexed

About

Cheng Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cheng Chen has authored 87 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 30 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Cheng Chen's work include MicroRNA in disease regulation (13 papers), RNA modifications and cancer (12 papers) and Cancer-related molecular mechanisms research (11 papers). Cheng Chen is often cited by papers focused on MicroRNA in disease regulation (13 papers), RNA modifications and cancer (12 papers) and Cancer-related molecular mechanisms research (11 papers). Cheng Chen collaborates with scholars based in China, United States and Hong Kong. Cheng Chen's co-authors include Jie Yang, Xiaoyuan Chu, Xiaolei Ma, Wen Sun, Jin Ding, Hongyang Wang, Liya Wang, Beifang Ning, Daimin Xiang and Xue Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Cheng Chen

84 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Chen China 30 1.9k 1.3k 471 248 234 87 3.3k
Fang Fěng China 35 1.7k 0.9× 608 0.5× 417 0.9× 149 0.6× 114 0.5× 170 3.8k
Yan Ding China 27 1.7k 0.9× 1.0k 0.8× 327 0.7× 205 0.8× 143 0.6× 160 3.3k
Yong Liao China 30 3.3k 1.8× 585 0.4× 1.3k 2.9× 322 1.3× 183 0.8× 98 5.2k
Javier Silva Spain 44 2.4k 1.3× 1.3k 1.0× 1.0k 2.2× 250 1.0× 727 3.1× 86 5.2k
Mingyue Li China 28 1.1k 0.6× 323 0.2× 240 0.5× 166 0.7× 497 2.1× 82 2.6k
Liping Hu China 26 1.1k 0.6× 198 0.2× 261 0.6× 157 0.6× 188 0.8× 105 2.5k
Qingsong Cai United States 25 1.6k 0.8× 954 0.7× 389 0.8× 176 0.7× 168 0.7× 56 2.8k
Lijun Wang China 34 1.9k 1.0× 303 0.2× 491 1.0× 298 1.2× 142 0.6× 141 3.7k
Yueqin Wang China 27 916 0.5× 341 0.3× 174 0.4× 155 0.6× 176 0.8× 66 2.2k
Zhao Yang China 26 1.2k 0.6× 571 0.4× 394 0.8× 178 0.7× 95 0.4× 84 2.4k

Countries citing papers authored by Cheng Chen

Since Specialization
Citations

This map shows the geographic impact of Cheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Chen more than expected).

Fields of papers citing papers by Cheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Chen. The network helps show where Cheng Chen may publish in the future.

Co-authorship network of co-authors of Cheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Chen. A scholar is included among the top collaborators of Cheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Chen. Cheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qing, Xue Qiao, Xiaodong Zeng, et al.. (2025). Benzothiazole amide analogues as antagonists of TRPC 6 channels: A therapeutic approach for kidney fibrosis. European Journal of Medicinal Chemistry. 291. 117628–117628. 2 indexed citations
2.
Chen, Cheng, Hezhen Wang, Lili Xu, et al.. (2024). MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia. Clinical Immunology. 268. 110355–110355. 1 indexed citations
3.
Zhang, Hang, Hao Tian, Cheng Chen, Chen Tian, & Wanchun Dou. (2024). A Blockchain-Assisted Federated Learning Method for Recommendation Systems. 58–65. 1 indexed citations
4.
5.
Chen, Cheng, et al.. (2023). Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1. World Journal of Gastrointestinal Oncology. 15(6). 988–1004. 1 indexed citations
6.
Chen, Cheng, Jinling Zhu, Xue Jiang, et al.. (2022). Amplified cyanobacterial bloom is derived by polyphosphate accumulation triggered by ultraviolet light. Water Research. 222. 118837–118837. 22 indexed citations
7.
Han, Siqi, Guangchao Li, Meng Jia, et al.. (2021). Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes. Frontiers in Molecular Biosciences. 8. 743013–743013. 40 indexed citations
8.
Yang, Xi, Cheng Chen, Li Li, et al.. (2021). Current research advances in microRNA-mediated regulation of Kruppel-like factor 4 in cancer: a narrative review. Annals of Translational Medicine. 9(11). 948–948. 4 indexed citations
9.
Ji, Xiaoqin, Chenglong He, Siqi Han, et al.. (2021). Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer. Frontiers in Oncology. 11. 659987–659987. 9 indexed citations
10.
Huang, Mengxi, Chenglong He, Cheng Chen, et al.. (2021). Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer. Frontiers in Oncology. 11. 650937–650937. 3 indexed citations
11.
Wang, Xiaohua, Guifang Xu, Jingyuan Zhang, et al.. (2019). The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis. Human Cell. 32(4). 487–494. 15 indexed citations
12.
Xiong, Huaping, Ting Yan, Weijie Zhang, et al.. (2018). miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer. Cellular Signalling. 44. 33–42. 68 indexed citations
13.
Shi, Xiaoshun, Allen Chen, Xiaobing Le, et al.. (2017). LncRNA TUSC7 affects malignant tumor prognosis by regulating protein ubiquitination: a genome-wide analysis from 10,237 pan-cancer patients. Translational Cancer Research. 6(4). 834–842. 1 indexed citations
14.
Li, Xiaofeng, Cheng Chen, Daimin Xiang, et al.. (2017). Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66(6). 1934–1951. 104 indexed citations
15.
Chen, Cheng, Jiayi Liu, Jiazi Shi, et al.. (2017). Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Molecular Cancer. 16(1). 111–111. 172 indexed citations
16.
Xie, Tao, Jian Geng, Ye Wang, et al.. (2016). FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 8(5). 8574–8589. 59 indexed citations
17.
Han, Tao, Daimin Xiang, Wen Sun, et al.. (2015). PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients. Journal of Hepatology. 63(3). 651–660. 124 indexed citations
18.
Wu, Yousheng, Dengke Bao, Jingyao Dai, et al.. (2015). Polymorphisms in Genes of the De Novo Lipogenesis Pathway and Overall Survival of Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(3). 1051–1056. 11 indexed citations
19.
Wen, Wen, Jin Ding, Wen Sun, et al.. (2012). Cyclin G1–mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology. 55(6). 1787–1798. 91 indexed citations
20.
Chen, Cheng, et al.. (2009). Photolytic destruction of endocrine disruptor atrazine in aqueous solution under UV irradiation: Products and pathways. Journal of Hazardous Materials. 172(2-3). 675–684. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Fěng Breakdown of academic impact, for papers by Yan Ding Breakdown of academic impact, for papers by Yong Liao Breakdown of academic impact, for papers by Javier Silva Breakdown of academic impact, for papers by Mingyue Li Breakdown of academic impact, for papers by Liping Hu Breakdown of academic impact, for papers by Qingsong Cai Breakdown of academic impact, for papers by Lijun Wang Breakdown of academic impact, for papers by Yueqin Wang Breakdown of academic impact, for papers by Zhao Yang
Rankless by CCL
2026